BAT Rothmans' flagship vaping brand, VUSE, has expanded its lineup to include a total of three options, following the addition of large-capacity and slim-type products late last year.

VUSE was a perennial underperformer, but a January 2023 strategy change provides new hope for shareholders of this all-cap fund with a 0.50% expense ratio. VUSE's current fundamentals are solid ...

At oral arguments earlier this week the Supreme Court was skeptical of the Food and Drug Administration’s effort to block a North Carolina-based company from challenging the denial of its application ...

The Supreme Court will hear oral arguments on Tuesday in a clash over whether a North Carolina-based company can challenge the Food and Drug Administration’s denial of its application to market ...

In the final days of President Joe Biden’s term, the US Food and Drug Administration (FDA) has placed a proposal that could ...

Launched on 01/22/2014, the Vident U.S. Equity Strategy ETF (VUSE) is a smart beta exchange traded fund offering broad exposure to the Style Box - All Cap Value category of the market. Market cap ...

The U.S. Supreme Court appeared skeptical Tuesday of the government's attempt to limit the number of Food and Drug ...

British American Tobacco operates as the world's second-largest tobacco company by volume, though global cigarette ...

"We neither like nor dislike the Fifth Circuit," Suri replied. "What we dislike is for the other side to be able to choose ...

Launched on 01/22/2014, the Vident U.S. Equity Strategy ETF (VUSE) is a smart beta exchange traded fund offering broad exposure to the Style Box - All Cap Value category of the market. Market cap ...